BACKGROUND: The objective of this study was to test a novel household-based approach to improve late-season influenza vaccine uptake during the 2020-2021 season, using Epic's MyChart patient portal messages and/or interactive voice response telephone calls. METHODS: This study was a non-blinded, quality improvement program using a block randomized design conducted among patients from Reliant Medical Group clinics residing in a traditional household (≥2 individuals clinically active in the Reliant system living at the same address). Households were randomized 1:1:1 into intervention arms: non-tailored communication (messaging based on CDC's seasonal influenza vaccination campaign), tailored communication (comprehensive communication including reinforcement of the importance of influenza vaccination for high-risk individuals), and standard-of-care control. Influenza vaccination during the program was captured via medical records, and the odds of vaccination among communication arms versus the control arm were assessed. A survey assessing influenza vaccination drivers was administered using MyChart. RESULTS: Influenza vaccination increased by 3.3% during the program period, and no significant differences in vaccination were observed in intervention arms relative to the control arm. Study operationalization faced substantial challenges related to the concurrent COVID-19 pandemic. Compared with vaccinated survey respondents, unvaccinated respondents less frequently reported receiving a recommendation for influenza vaccination from their healthcare provider (15.8% vs. 42.3%, p < 0.001) or awareness that vaccination could protect themselves and higher risk contacts (82.3% vs. 92.6%, p < 0.001). CONCLUSIONS: No significant effects of the interventions were observed. Survey results highlighted the importance of healthcare provider recommendations and the need for increased education around the benefits of vaccination.
BACKGROUND: The objective of this study was to test a novel household-based approach to improve late-season influenza vaccine uptake during the 2020-2021 season, using Epic's MyChart patient portal messages and/or interactive voice response telephone calls. METHODS: This study was a non-blinded, quality improvement program using a block randomized design conducted among patients from Reliant Medical Group clinics residing in a traditional household (≥2 individuals clinically active in the Reliant system living at the same address). Households were randomized 1:1:1 into intervention arms: non-tailored communication (messaging based on CDC's seasonal influenza vaccination campaign), tailored communication (comprehensive communication including reinforcement of the importance of influenza vaccination for high-risk individuals), and standard-of-care control. Influenza vaccination during the program was captured via medical records, and the odds of vaccination among communication arms versus the control arm were assessed. A survey assessing influenza vaccination drivers was administered using MyChart. RESULTS: Influenza vaccination increased by 3.3% during the program period, and no significant differences in vaccination were observed in intervention arms relative to the control arm. Study operationalization faced substantial challenges related to the concurrent COVID-19 pandemic. Compared with vaccinated survey respondents, unvaccinated respondents less frequently reported receiving a recommendation for influenza vaccination from their healthcare provider (15.8% vs. 42.3%, p < 0.001) or awareness that vaccination could protect themselves and higher risk contacts (82.3% vs. 92.6%, p < 0.001). CONCLUSIONS: No significant effects of the interventions were observed. Survey results highlighted the importance of healthcare provider recommendations and the need for increased education around the benefits of vaccination.
Authors: Daniel B Fishbein; John Fontanesi; David Kopald; John Stevenson; Nancy M Bennett; David W Stryker; Christine Long; Margaret S Coleman; Abigail M Shefer Journal: Vaccine Date: 2005-08-18 Impact factor: 3.641
Authors: Madhura S Rane; Shivani Kochhar; Emily Poehlein; William You; McKaylee M Robertson; Rebecca Zimba; Drew A Westmoreland; Matthew L Romo; Sarah G Kulkarni; Mindy Chang; Amanda Berry; Angela M Parcesepe; Andrew R Maroko; Christian Grov; Denis Nash Journal: Am J Epidemiol Date: 2022-03-24 Impact factor: 4.897
Authors: Sarah L Cutrona; Jessica G Golden; Sarah L Goff; Jessica Ogarek; Bruce Barton; Lloyd Fisher; Peggy Preusse; Devi Sundaresan; Lawrence Garber; Kathleen M Mazor Journal: J Gen Intern Med Date: 2018-01-30 Impact factor: 5.128
Authors: Linda C Karlsson; Anna Soveri; Stephan Lewandowsky; Linnea Karlsson; Hasse Karlsson; Saara Nolvi; Max Karukivi; Mikael Lindfelt; Jan Antfolk Journal: Pers Individ Dif Date: 2020-12-14
Authors: Julie C Jacobson Vann; Robert M Jacobson; Tamera Coyne-Beasley; Josephine K Asafu-Adjei; Peter G Szilagyi Journal: Cochrane Database Syst Rev Date: 2018-01-18
Authors: Jeanine P D Guidry; Linnea I Laestadius; Emily K Vraga; Carrie A Miller; Paul B Perrin; Candace W Burton; Mark Ryan; Bernard F Fuemmeler; Kellie E Carlyle Journal: Am J Infect Control Date: 2020-11-20 Impact factor: 2.918
Authors: Lloyd Fisher; Matthew M Loiacono; Nick Payne; Tina Kelley; Michael Greenberg; Mary Charpentier; Candace Leblanc; Devi Sundaresan; Tim Bancroft; Andrea Steffens; Misti Paudel Journal: Influenza Other Respir Viruses Date: 2022-09-13 Impact factor: 5.606